Physical, morphological and functional differences between pH 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Aβ

Journal of Molecular Biology

Volumn 256, Issue 5, 1996, Pages 870-877

  Wood, Stephen J ^a   Maleeff, Beverly ^a   Hart, Timothy ^a   Wetzel, Ronald ^a,b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b NONE   (United States)

Author keywords

Congo red; Electron microscopy; Fibrils; Light scattering; Lysosome; Thioflavin T; Turbidity

Indexed keywords

AMYLOID A PROTEIN; CONGO RED; THIOFLAVINE;

ALZHEIMER DISEASE; ARTICLE; BINDING SITE; FIBER; HUMAN; LIGHT SCATTERING; LYSOSOME; MICROSCOPY; PH; PRIORITY JOURNAL;

EID: 0029996091     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1996.0133     Document Type: Article

References (24)

1. Barrow, C. J. & Zagorski, M. G. (1991). Solution structures of β peptide and its constituent fragments: Relation to amyloid deposition. Science, 253, 179-182.
2. Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C. & Glabe, C. (1992). Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J. Biol. Chem. 267, 546-554.
3. Buxbaum, J. (1992). Mechanisms of disease: Monoclonal inmmunoglobulin deposition. Hemat. Oncol. Clin. North America, 6, 323-346.
4. Campbell, I. D. & Dwek, R. A. (1984). Biological Spectroscopy, Benjamin/Cummings, Menlo Park, CA.
5. Colon, W. & Kelly, J. W. (1992). Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry, 31, 8654-8660.
6. Evans, K. C., Berger, E. P., Cho, C.-G., Weisgraber, K. H. & Lansbury P. T., Jr (1995). Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: Implications for the pathogenesis and treatment of Alzheimer disease. Proc. Natl Acad. Sci. USA, 92, 763-767.
7. Fraser, P. E., Nguyen, J. T., Surewicz, W. K. & Kirschner, D. A. (1991). pH-dependent structural transitions of Alzheimer amyloid peptides. Biophys. J. 60, 1190-1201.
8. Glenner, G. G., Ein, D., Eanes, E. D., Bladen, H. A., Terry, W. & Page, D. L. (1971). Creation of "amyloid" fibrils from Bence Jones proteins in vitro. Science, 174, 712-714.
9. Helms, L. R. & Wetzel, R. (1996). Specificity of abnormal assembly in immunoglobulin light chain deposition disease and amyloidosis. J. Mol. Biol. In the press.
10. Hewlett, D. R., Jennings, K. H., Lee, D. C., Clark, M. S. G., Brown, F., Wood, S. J., Wetzel, R., Camilleri, P. & Roberts, G. W. (1995). Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide. Neurodegeneration, 4, 23-32.
11. Jarrett, J. T. & Lansbury, P. J. (1992). Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB. Biochemistry, 31, 123435-12352.
12. Jarrett, J. T., Berger, E. P. & Lansbury, P. T., Jr (1993). The carboxy terminums of the b amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry, 32, 4693-4697.
13. Multhaup, G., Masters, C. L. & Beyreuther, K. (1993). A molecular approach to Alzheimer's disease. Biol. Chem. Hoppe-Seyler, 374, 1-8.
14. Pike, C. J., Burdick, D., Walencewicz, A. J., Glabe, C. G. & Cotman, C. W. (1993). Neurodegeneration induced by β-amyloid peptides in vivo: the role of peptide assembly state. J. Neurosci. 13, 1676-1687.
15. Selkoe, D. J. (1991). The molecular pathology of Alzheimer's disease. Neuron, 6, 487-498.
16. Selkoe, D. J. (1994). Normal and abnormal biology of the β-amyloid precursor protein. Annu. Rev. Neurosci. 17, 489-517.
17. Selkoe, D. J. (1995). Missense on the membrane. Nature, 375, 734-735.
18. Seubert, P., Vigo-Pelfrey C., Esch, F., Lee, M., Dovey H., Davis, D., Sinha, S., Schlossmacher, M., Whaley J., Swindlwhurst, C., McCormack, R., Wolfert, R., Selkoe, D., Lieberburg, I. & Schenk, D. (1992). Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature, 359, 325-327.
19. Shen, C.-L., Fitzgerald, M. C. & Murphy, R. M. (1994). Effect of acid predissolution on fibril size and fibril flexibility of synthetic β-amyloid peptide. Biophys. J. 67, 1238-1246.
20. Shirahama, T. & Cohen, A. S. (1975). Intralysosomal formation of amyloid fibrils. Am. J. Path. 81, 101-116.
21. Sisodia, S. S. & Price, D. L. (1992). Amyloidogenesis in Alzheimer's disease: basic biology and animal models. Curr. Opin. Neurobiol. 2, 648-652.
22. Snyder, S. W., Ladror, U. S., Wade, W. S., Wang, G. T., Barrett, L. W., Matayoshi, E. D., Huffaker, H. J., Krafft, G. A. & Holzman, T. F. (1994). Amyloid-β aggregation: selective inhibition in mixtures of amyloid with different chain lengths. Biophys. J. 67, 1216-1228.
23. Westermark, P. (1994). Amyloid and polypeptide hormones: what is their relationship? Amyloid, 1, 47-60.
24. Westermark, P., Sletten, K., Johansson, B. & Cornwell, G. G. 3. (1990). Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc. Natl Acad. Sci. USA, 87, 2843.